Clinical Trials Logo

Clinical Trial Summary

In patients undergoing robot-assisted radical prostatectomy (RARP), pneumoperitoneum, intraoperative fluid restriction and prolonged Trendelenburg position may cause rhabdomyolysis (RM) due to hypoperfusion in gluteal muscles and lower extremities.

In this study, it was aimed to assess effects of BMI, comorbidities, intraoperative positioning, fluid restriction and length of surgery on development of RM in RARP patients during perioperative period.


Clinical Trial Description

Fifty-two ASA I-II patients aged 50-80 years, BMI >25 kg/m2 scheduled for an elective RARP were enrolled to the study.

In all patients, pre-anesthetic evaluations including laboratory tests and Charlson Comorbidity Index (CCI) were performed one week before surgery in anesthesia clinic. Comorbid diseases were rated based on CCI. A 4-points scale was used to rate comorbid conditions [1 mild; 4 severe]. Comorbidity grading was performed by adding scores given for each comorbid disease. Based on the grading, patients were stratified into 4 groups as follows: grade 0, 1-2, 3-4 and ≥ 5

In the operation room, intubation was performed after standard anesthesia For surgery, patients were placed in low lithotomy position. All patients were placed on a soft sponge mattress and soft padding gel pads were provided above the shoulders. The patients were placed in a 30-degree STP after achieving pneumoperitoneum at an intra-abdominal pressure level of 15 mmHg. After placing patient to desired position (T0), blood samples were drawn for measurements of ABG, Na, Cl, Ca, K, BUN, Cr, AST, ALT, LDH, cTp-I, CK-MB and CPK.

During the operation, normal saline (1 m/kg/hr) and 6% HES 200/05 (1 ml/kg/hr) infusions were applied. Operation time (OT) and Trendelenburg time (TT) were recorded in all patients.

Blood samples were repeated on the hours 6 (T6), 12 (T12) and 24 (T24) after beginning of surgery. Hydration with 2000 ml crystalloid solution was given until hour 24 after surgery. In all patients, urine output was monitored.

Rhabdomyolysis was defined as postoperative serum CPK level exceeding 5,000 IU/L. It was planned to manage these patients with hypervolemic therapy, correction of acidosis by using IV sodium bicarbonate and stimulation of diuresis by IV furosemide with a goal of maintaining minimal diuresis of 60 ml/hr at pH level of 7.

Postoperative RF was defined as an increase in serum creatinine of 1mg/dl/day (or 90 mmol/l/day) for 2 consecutive days beyond the baseline.

Patients were discharged with control laboratory tests, including the same parameters, on the hour 48 (T48) postoperatively. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02671604
Study type Observational [Patient Registry]
Source Umraniye Education and Research Hospital
Contact
Status Completed
Phase N/A
Start date January 2014
Completion date January 2015

See also
  Status Clinical Trial Phase
Completed NCT03737513 - Exercise-induced Collective Rhabdomyolysis
Completed NCT00241748 - Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event N/A
Not yet recruiting NCT02498366 - Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty N/A
Not yet recruiting NCT06429982 - Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols Phase 1
Active, not recruiting NCT06101680 - RhabdomYolyse in Intensive caRe
Withdrawn NCT02896517 - Support for the Rhabdomyolysis in an Emergency Department
Completed NCT01467180 - Myoglobin Removal by High Cut-off CVVHD N/A
Recruiting NCT01022450 - Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients N/A
Completed NCT00391911 - Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis Phase 2
Withdrawn NCT02111018 - Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis Phase 2
Completed NCT04913298 - Prospective Study for the Application of Cytosorb® in Critically Ill Patients N/A
Recruiting NCT05146336 - CytOSorb TreatMent Of Critically Ill PatientS Registry
Completed NCT03986736 - Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
Not yet recruiting NCT02518724 - The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis N/A
Completed NCT00592657 - Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions N/A
Completed NCT06338423 - Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure N/A
Completed NCT01976936 - Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2 Phase 2
Completed NCT04118608 - Rhabdomyolysis - a Study of Patient Characteristics and Laboratory Values to Guide Treatment
Completed NCT01544231 - Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis N/A
Recruiting NCT00549029 - The Association of Genetic Polymorphisms With Statin-Induced Myopathy. N/A